Literature DB >> 14168000

HEPARIN--A CAUSE OF ARTERIAL EMBOLI?

B ROBERTS, F E ROSATO, E F ROSATO.   

Abstract

Entities:  

Keywords:  BRACHIAL ARTERY; CATHETERIZATION; DRUG THERAPY; EMBOLISM; FEMORAL ARTERY; GERIATRICS; HEPARIN; PATHOLOGY; PULMONARY EMBOLISM; THROMBOPHLEBITIS; THROMBOSIS; TOXICOLOGIC REPORT; VASCULAR SURGERY

Mesh：

Substances：

Year:  1964        PMID： 14168000

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  15 in total

Review 1.  Heparin-induced thrombocytopenia and thrombosis.

Authors:  G Arepally; D B Cines
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 2.  Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.

Authors:  J M Walenga; W P Jeske; H L Messmore
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

3.  Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia?

Authors:  Christopher Lancaster; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01

Review 4.  HITs and misses in 100 years of heparin.

Authors:  Lawrence Rice
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 5.  Effect of heparin and heparin fractions on platelet aggregation.

Authors:  E W Salzman; R D Rosenberg; M H Smith; J N Lindon; L Favreau
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

6.  The dangers of intermitten intravenous heparin therapy.

Authors:  F H Spracklen; D G Model; E M Besterman
Journal:  Postgrad Med J       Date:  1966-11       Impact factor: 2.401

7.  Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.

Authors:  E Magnus Ohman; Christopher B Granger; Lawrence Rice; Charles S Abrams; Richard C Becker; Peter B Berger; Neal S Kleiman; David Moliterno; Stephan Moll; Jo E Rodgers; Stephen S Steinhubl; Victor F Tapson; Peter Sinnaeve; Kevin J Anstrom
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

8.  Heparin-induced thrombocytopenia, thrombosis, and hemorrhage.

Authors:  D Silver; D N Kapsch; E K Tsoi
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

9.  Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

Authors:  G P Visentin; S E Ford; J P Scott; R H Aster
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 10.  Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Authors:  Harry Messmore; Walter Jeske; William Wehrmacher; Jeanine Walenga
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.